XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
 9 Months Ended
Sep. 28, 2025
Earnings Per Share [Abstract]  
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders
The following presents the detailed calculation of EPS:
 Three Months EndedNine Months Ended
(MILLIONS)September 28,
2025		September 29,
2024		September 28,
2025		September 29,
2024
EPS Numerator
Income from continuing operations attributable to Pfizer Inc. common shareholders$3,541 $4,473 $9,393 $7,617 
Discontinued operations––net of tax— (8)25 4 
Net income attributable to Pfizer Inc. common shareholders$3,541 $4,465 $9,419 $7,621 
EPS Denominator    
Weighted-average number of common shares outstanding––Basic5,685 5,667 5,682 5,663 
Common-share equivalents29 39 29 36 
Weighted-average number of common shares outstanding––Diluted5,714 5,705 5,710 5,699 
Anti-dilutive common stock equivalents(a)
8 25 11 25 
(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.